IP Verse

Becker patent opposition analysis

The comprehensive analysis of Becker opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Becker

Stay updated with the latest patent oppositions filed by Becker

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3717634
Methods For Activating, Modifying And Expanding Gamma Delta T Cells For The Treatment Of Cancer And Related MalignanciesIMMATICS US, INC.Jul 13, 2026MILTENYI BIOTEC
EP3749353
Nemolizumab In The Treatment Of Atopic Dermatitis With Moderate To Severe ExcoriationGALDERMA HOLDING SAApr 30, 2026CABINET BECKER ET ASSOCIES
EP4008329
Isoxazoline Compounds For Use In Treating DemodicosisINTERVET INTERNATIONAL B.V.Mar 11, 2026CEVA SANTE ANIMALE
EP3236960
Use Of Isoxazoline Compounds For Treating DemodicosisINTERVET INTERNATIONAL B.V.Oct 28, 2025CEVA SANTE ANIMALE
EP4013466
Method For In Vitro Production Of Hyaline Cartilage TissueVANARIX SAJul 16, 2025CABINET BECKER ET ASSOCIES
EP3790946
Process For Enzymatic Oil DegummingDSM IP ASSETS B.V.Jul 8, 2025CABINET BECKER ET ASSOCIES
EP3989352
Secondary Battery, Battery Module, And Device Using Battery As Power SourceCONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITEDMay 21, 2025BECKER
EP3485890
Treatment Of Metabolic Disorders In Canine AnimalsBOEHRINGER INGELHEIMFeb 9, 2024CEVA SANTE ANIMALE
EP3035958
Porcine Circovirus Type 2 (Pcv2) Subunit VaccineBOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.Jul 26, 2023CEVA SANTE ANIMALE
EP3440243
Biodegradable Polyamide Fiber, Process For Obtaining Such Fiber And Polyamide Article Made TherefromRHODIA POLIAMIDA E ESPECIALIDADESMar 21, 2023NILIT LTD.

Top clients of Becker

Top companies who are the clients of Becker

CompanyTotal
CEVA SANTE ANIMALE19
BECKER7
LAIR LIQUIDE5
CABINET BECKER ET ASSOCIES4
FEDERAL MOGUL WIESBADEN4
PURE11 GMBH3
FEDERAL-MOGUL VALVETRAIN GMBH3
FEDERAL-MOGUL BURSCHEID GMBH3
SAINT GOBAIN3
AGROBIOGEN2